Published in Lancet on August 20, 1983
Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules. Proc Natl Acad Sci U S A (1984) 1.35
Remission of postmenopausal breast cancer during treatment with the luteinising hormone releasing hormone agonist ICI 118630. Br J Cancer (1986) 1.30
Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model. Proc Natl Acad Sci U S A (1985) 0.86
Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model. Proc Natl Acad Sci U S A (1986) 0.85
Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer. Br Med J (Clin Res Ed) (1985) 0.84
Hormonal aspects of prostatic cancer: a review. J R Soc Med (1985) 0.80
Analogues of gonadotrophin releasing hormone. Br Med J (Clin Res Ed) (1984) 0.79
Treatment of advanced carcinoma of the prostate. Br Med J (Clin Res Ed) (1984) 0.75
Failure of long term luteinising hormone releasing hormone treatment for prostatic cancer to suppress serum luteinising hormone and testosterone. Br Med J (Clin Res Ed) (1984) 0.75
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial. Lancet (2002) 6.02
Dissociation between steroid receptor expression and cell proliferation in the human breast. Cancer Res (1997) 4.22
An in vitro method for assessing the plaque forming ability of oral bacteria. Arch Oral Biol (1967) 3.11
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
Bladder trauma in the long-distance runner: "10,000 metres haematuria". Br J Urol (1977) 2.99
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial. Lancet Oncol (2006) 2.94
A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer (1984) 2.89
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer. Br J Cancer (2004) 2.87
Does pericapsular lignocaine reduce pain during transrectal ultrasonography-guided biopsy of the prostate? BJU Int (2002) 2.64
Familial breast cancer. BMJ (1994) 2.54
Uptake of screening and prevention in women at very high risk of breast cancer. Lancet (2001) 2.45
Treatment of advanced breast cancer with sterically stabilized liposomal doxorubicin: results of a multicenter phase II trial. J Clin Oncol (1997) 2.39
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology (1995) 2.27
Pituitary function after treatment of intracranial tumours in children. Lancet (1975) 2.25
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet (2003) 2.24
The prevalence of severe growth hormone deficiency in adults who received growth hormone replacement in childhood [see comment]. Clin Endocrinol (Oxf) (1996) 2.03
Clinical studies of multiple endocrine neoplasia type 1 (MEN1) QJM (1996) 1.93
Testicular function following chemotherapy. Hum Reprod Update (2001) 1.90
High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy. Breast Cancer Res Treat (2001) 1.88
Does growth hormone cause cancer? Clin Endocrinol (Oxf) (2006) 1.86
Endocrine function following the treatment of acute leukemia in childhood. J Pediatr (1977) 1.86
Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat (1999) 1.84
Screening for psychiatric morbidity in patients with advanced breast cancer: validation of two self-report questionnaires. Br J Cancer (1991) 1.83
Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. Br J Cancer (2007) 1.80
Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab (1997) 1.79
Dose dependency of time of onset of radiation-induced growth hormone deficiency. J Pediatr (1991) 1.76
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med (1989) 1.74
High pressure chronic retention. Br Med J (Clin Res Ed) (1983) 1.70
Zoledronic acid reduces skeletal-related events in patients with osteolytic metastases. Cancer (2001) 1.70
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer. Eur J Cancer (1996) 1.67
The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. Br J Cancer (1989) 1.65
Cranial irradiation and early puberty. J Clin Endocrinol Metab (1994) 1.64
The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism. Clin Endocrinol (Oxf) (1994) 1.61
The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women. Int J Obes (Lond) (2010) 1.61
The prognostic significance of two epithelial membrane antigens expressed by human mammary carcinomas. Int J Cancer (1984) 1.61
Odontomyces viscosus, gen. nov., spec. nov., a filamentous microorganism isolated from periodontal plaque in hamsters. Sabouraudia (1965) 1.61
Assessment of hormone dependence of comedo ductal carcinoma in situ of the breast. J Natl Cancer Inst (1997) 1.58
Testicular histology after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Lancet (1978) 1.57
Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol (2007) 1.57
Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet (1984) 1.56
The pharmacokinetics of Casodex in prostate cancer patients after single and during multiple dosing. Eur Urol (1990) 1.55
Thyroid function after treatment of brain tumors in children. J Pediatr (1991) 1.53
Estrogen responsiveness and control of normal human breast proliferation. J Mammary Gland Biol Neoplasia (1998) 1.52
A filamentous microorganism isolated from periodontal plaque in hamsters. 1. Isolation, morphology and general cultural characteristics. Sabouraudia (1963) 1.52
Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr (2005) 1.52
Growth hormone deficiency and replacement in adults. BMJ (1996) 1.50
Normal growth despite abnormalities of growth hormone secretion in children treated for acute leukemia. J Pediatr (1979) 1.50
Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol (1996) 1.49
Can hair be used to screen for breast cancer? J Med Genet (2000) 1.49
High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr (1995) 1.46
The long-term results of Anderson-Hynes pyeloplasty. BJU Int (2001) 1.45
A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45
Growth hormone replacement and the risk of malignancy in children with neurofibromatosis. J Pediatr (1998) 1.44
Neuropathic joints. Semin Arthritis Rheum (1972) 1.44
Screening by mammography, women with a family history of breast cancer. Eur J Cancer (1998) 1.44
Anastrozole, a potent and selective aromatase inhibitor, versus megestrol acetate in postmenopausal women with advanced breast cancer: results of overview analysis of two phase III trials. Arimidex Study Group. J Clin Oncol (1996) 1.44
Abdominal irradiation in childhood; the potential for pregnancy. Br J Obstet Gynaecol (1992) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer. Cancer Res (1994) 1.43
Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations. Clin Endocrinol (Oxf) (1994) 1.42
Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J Clin Endocrinol Metab (1999) 1.42
The relationship of body weight to response to endocrine therapy, steroid hormone receptors and survival of patients with advanced cancer of the breast. Br J Cancer (1988) 1.42
Residual disabilities in children treated for intracranial space-occupying lesions. Cancer (1976) 1.41
Adult panhypopituitarism presenting as idiopathic growth hormone deficiency in childhood. Acta Paediatr Scand (1991) 1.40
Effect of clothing on dispersal of Staphylococcus aureus by males and females. Lancet (1974) 1.39
Changes in lipoprotein(a) levels measured by six kit methods during growth hormone treatment of growth hormone-deficient adults. Growth Horm IGF Res (2000) 1.39
An open randomised trial of second-line endocrine therapy in advanced breast cancer: comparison of the Aromatase inhibitors letrozole and anastrozole. Eur J Cancer (2004) 1.39
The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc Natl Acad Sci U S A (1989) 1.38
The response of prostatic fluid pH in inflammation. Br J Urol (1974) 1.37
Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer. Eur J Cancer (1993) 1.36
Growth hormone deficiency after treatment of acute leukaemia in children. Arch Dis Child (1976) 1.36
Controlled trial of adjuvant chemotherapy with melphalan for breast cancer. Lancet (1983) 1.35
A filamentous microorganism isolated from periodontal plaque in hamsters. II. Physiological and biochemical characteristics. Sabouraudia (1963) 1.34
Screening colonoscopy for acromegaly in perspective. Clin Endocrinol (Oxf) (2001) 1.33
Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psychooncology (1999) 1.32
Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol (1989) 1.32
The effect of varying doses of cerebral irradiation on growth hormone production in childhood. Clin Endocrinol (Oxf) (1976) 1.31
Growth hormone and tumour recurrence. BMJ (1992) 1.30
Mechanism of action of adjuvant chemotherapy in early breast cancer. Lancet (1986) 1.30
Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet (2001) 1.28
Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer (1994) 1.28
Carcinomatous meningitis in solid tumours. Ann Oncol (1996) 1.27
The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer (1982) 1.26
Ovarian failure following abdominal irradiation in childhood: natural history and prognosis. Clin Oncol (R Coll Radiol) (1989) 1.26
Histological detection of oestrogen receptor in human breast carcinomas. Lancet (1980) 1.26
A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. Br J Cancer (1984) 1.25
Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Metab (1990) 1.25
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with axillary node-positive breast cancer: an update of the Guy's/Manchester trial. J Clin Oncol (1990) 1.25
Effects of oestrogen on gene expression in epithelium and stroma of normal human breast tissue. Endocr Relat Cancer (2006) 1.24
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer. J Med Genet (2011) 1.23
Sclerosis of lytic bone metastases after disodium aminohydroxypropylidene bisphosphonate (APD) in patients with breast carcinoma. BMJ (1988) 1.23
Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child (1981) 1.22